Tagged Articles

District of Columbia 73 articles

EPA’s recommendations on coal ash the focus of dispute

As the Environmental Protection Agency (EPA) ponders how waste from coal-firing plants should be classified, the debate on how best to regulate the toxic material heats up. Here is one more view on The Coal Ash Case, from The New York Times. Editorial: The Coal Ash Case Published January 19, 2010, The New York Times Just more than a year ago, one billion tons of toxic coal sludge broke loose from a containment pond belonging to the Tennessee Valley Authority, burying hundreds of acres of Roane County in eastern Tennessee and threatening local water supplies and air quality. The Environmental ... Read More

CPSC info center helps consumers living with toxic Chinese drywall

The federal government has launched a new section of its web site called the Drywall Information Center. The agency developed the section in an effort to field consumer questions and complaints about the influx of tainted Chinese-made drywall to the U.S. that occurred in 2006 and 2007 when domestic drywall supplies ran low. The U.S. Consumer Product Safety Commission says it has received close to 2,000 reports of drywall ruining electrical wiring, air conditioner coils, fixtures, and appliances because it emits corrosive sulfuric fumes. Homeowners affected by the Chinese drywall also report a variety of respiratory health problems and a constant foul odor ... Read More

Justice Dept. hits Pfizer with $2.3 billion in fines and civil penalties

With the nation’s healthcare system groaning under epic pressure, you would think that the pharmaceutical giants would be a little more judicious in the way they promote their drugs and sell them to federal, state, and municipal government programs. Perhaps they will be, now that the United States Department of Justice has slapped Pfizer with a record $2.3 billion fine for defrauding the Medicare and Medicaid programs. Pfizer has agreed to pay $1.3 billion in criminal penalties to the Justice Department for its illegal promotion of Bextra, a nonsteroidal anti-inflammatory drug used to treat arthritis and menstrual pain. Pfizer followed ... Read More